Senior Diabetes Care Specialist
Current• Promoted a portfolio of endocrine injectable therapeutics including Tresiba and Ozempic and oral Rybelsus.• Called on Endocrinology, Cardiology, IM, and FP providers in the Indianapolis/Columbus/Bloomington regions. • Focused account management efforts and complete a total office call for over 250 physician clients/accounts.• Provided education to healthcare providers on disease state management and options for optimal treatment.• Implemented actionable business plans to increase market share and pull through in a managed care environment.• Developed and implemented strategic marketing initiatives to drive business development and surpass sales goals.• Employed relationship based and consultative sales approach understanding physicians approach and needs.• Cultivated relationships with Key Opinion Leaders (KOL) and developed speaker programs for the territory. • Influenced decisions for favorable formulary placement working with P&T Committees and key decision makers. • Collaborated with Account Executives, Diabetes Educators, Managers, and MSLs for promotion and patient support.• Initiated and led monthly calls focused on improving sales skills, disease-state knowledge and overcoming barriers.• Key Accomplishments:- Recognized with the Rybelsus 100 Club Award in 2022.- Achieved 103.6% to goal for Ozempic and 96.5% to goal Rybelsus-composite of 100.1% in Q4 2021.- Placed Top 5 on Ozempic Leaderboard 106% to goal in December 2021.- Won the Center of Excellence Award in 2019 (ranking 1/90) and in 2020 (ranking 5/90).- Increased Ozempic Sub MS over 5% and increased Rybelsus writers over 300% in 2021.- Led and implemented the first ever virtual Capni Conference 2021.- Selected to serve as the District WINN Lead, Ascension Health Lead, and Pharmacy Lead in 2021.- Executed numerous successful product launches including Rybelsus, Tresiba, Victoza, Xultophy and Ozempic. - Selected as a Focus Group Leader for the Rybelsus Launch 2018.